Article
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
2025-04-18
Abstract excerpt
The RNA-binding protein IGF2BP3 is an oncofetal protein overexpressed in B-acute lymphoblastic leukemia and is critical for leukemogenesis in experimental models. With cancer-specific expression, functional dispensability for normal development, and an unleveraged pro-oncogenic function in mRNA homeostasis, IGF2BP3 represents an excellent target. With no small molecule inhibitors of IGF2BP3 in clinical use, we und...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40a841d5-3bba-52f4-97fc-e2e642112afb
- DOI
- 10.1101/2025.04.14.648780
